Pharmaceuticals & Therapeutics

From cryopreservation to ethical news, a new generation of entrepreneurs is emerging from the Southeast, proving that business can be a force for good.

Federal aid covers food, but not soap. A new initiative tackles the hidden crisis of hygiene poverty that keeps thousands of Colorado students out of school.

As Alkermes prepares for a key investor conference, it's not just about numbers. It's about a bold new strategy in sleep medicine, a billion-dollar pipeline, and a new CEO.

As CEO Reshma Kewalramani takes the stage, investors will look for clues on how Vertex plans to pivot from CF dominance to a multi-franchise powerhouse.

The industrial gas giant's largest-ever membrane facility investment isn't just a local jobs boom; it's a calculated move to dominate the future of energy.

Parnell's new Sevoflurane offering is more than a product line extension; it's a strategic move to become a one-stop-shop for veterinary anesthesia.

Zepto Life Technology's FDA Breakthrough status for a fungal test isn't just a win for patients; it's a strategic move in liquid biopsy's new frontier.

With a severe shortage of addiction specialists, one treatment provider is launching a university. Is this the model to scale expertise and finally turn the tide?

The men's supplement industry is shifting from pure performance to holistic vitality. A new launch reveals the economic and scientific forces driving this change.

New long-term data for UPLIZNA and TAVNEOS show sustained disease control and reduced steroid use, offering a tangible difference for rare disease patients.

With a potential $4 billion on the line, CytomX and Regeneron are building a new class of cancer therapies designed to act like autonomous agents in the body.

Nirrin Technologies launches TALOS™, a system using novel laser spectroscopy to eliminate dilution and variability, promising a new standard for biomanufacturing.

PBI-Gordon's strategic hire of Kent Luther for Pegasus Labs signals a major push in animal health, blending big pharma talent with an employee-owned model.

A $1.2B rare earth magnet factory in Cherokee County wasn't just luck. It was the result of a two-decade-old playbook that's rewriting economic development.

As Alexandria grapples with a documented mental health crisis, a new clinic introduces advanced TMS and ketamine therapies to a region burdened by long waits.

A parent-founded nonprofit is funding a landmark gene therapy trial, aiming to create the first-ever treatment for a rare neurodevelopmental disorder.

The Motherhood Choice Awards are more than a ceremony. They are the public face of a complex digital ecosystem designed to guide Malaysian parents through a maze of choices.

New data reveals most Americans are less hydrated than they think. One company is turning this public health gap into a massive business opportunity.

Illicit tobacco costs the EU billions, and a new report from Philip Morris International blames bad policy. But a closer look reveals a story of shifting criminal tactics and a corporate giant shaping the narrative to its own advantage.

As the world grapples with drug-resistant bacteria, an Israeli biotech is testing a novel drug that physically destroys pathogens. Can it turn the tide?